Nakamura, M <br/><br/>
Recombinant human megakaryocyte growth and development factor attenuates postbypass thrombocytopenia.  [electronic resource] 

 -  The Annals of thoracic surgery  Oct 1998 
 - 1216-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4975 
<br/><br/><label>Standard No.: </label>10.1016/s0003-4975(98)00807-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Coagulation--drug effects<br/>Blood Platelets--drug effects<br/>Cardiopulmonary Bypass--adverse effects<br/>Dogs<br/>Humans<br/>Hypothermia, Induced<br/>Injections, Subcutaneous<br/>Platelet Aggregation--drug effects<br/>Platelet Count--drug effects<br/>Polyethylene Glycols--administration & dosage<br/>Preoperative Care<br/>Recombinant Proteins--administration & dosage<br/>Thrombocytopenia--etiology<br/>Thrombopoietin--administration & dosage<br/>Time Factors